Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments

Renal medullary carcinoma (RMC) is a rare, aggressive disease that predominantly afflicts individuals of African or Mediterranean descent with sickle cell trait. RMC comprises 1% of all renal cell carcinoma diagnoses with a median overall survival of 13 months. Patients are typically young (median a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Darmood, Yang, Youfeng, Ricketts, Christopher J., Vocke, Cathy D., Ball, Mark W., Sourbier, Carole, Wangsa, Darawalee, Wangsa, Danny, Guha, Rajarshi, Zhang, Xiaohu, Wilson, Kelli, Chen, Lu, Meltzer, Paul S., Ried, Thomas, Thomas, Craig J., Merino, Maria J., Linehan, W. Marston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383978/
https://www.ncbi.nlm.nih.gov/pubmed/32259323
http://dx.doi.org/10.1002/gcc.22847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383978/
https://www.ncbi.nlm.nih.gov/pubmed/32259323
http://dx.doi.org/10.1002/gcc.22847

Ejemplares similares